The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 15, 2026

Study Completion Date

December 15, 2026

Conditions
Endometriosis
Interventions
PROCEDURE

100 women undergoing surgery (laparoscopy / laparotomy) with presumed diagnosis of endometriosis

"1. We Will take Both blood and tissue samples used to study them.~2. We Will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery.~3. Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment.~4. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis."

PROCEDURE

women with intraoperative and / or histopathology findings suggestive of endometriosis

"1. We Will take Both blood and tissue samples used to study them.~2. We Will take approximately 3 ml of blood which will be used from the blood sample collected for routine preoperative tests (Surgical profile) before their planned surgery.~3. Small tissue samples will be taken from the tissue which is surgically excised as a part of treatment.~4. It will include tissue from inner lining of uterus (endometrium) in all participants and from excised endometriosis tissue in patients with endometriosis."

Trial Locations (1)

500082

Shraddha Ramchandani, Hyderabad

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER

NCT06168097 - The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis | Biotech Hunter | Biotech Hunter